Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy

Ken Sato; Yuichi Yamazaki; Yuki Kanayama; Daisuke Uehara; Hiroki Tojima; Takayoshi Suga; Satoru Kakizaki; Naondo Sohara; Norio Horiguchi; Toshio Uraoka

doi:10.1002/ccr3.5690

Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy

Clin Case Rep. 2022 Apr 5;10(4):e05690. doi: 10.1002/ccr3.5690. eCollection 2022 Apr.

Authors

Affiliations

¹ Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.
² Department of Hepatology Heisei Hidaka Clinic Gunma Japan.
³ Department of Gastroenterology National Hospital Organization Takasaki General Medical Center Gunma Japan.
⁴ Sohara Clinic Gunma Japan.
⁵ Department of General Medicine Gunma University Graduate School of Medicine Gunma Japan.

Abstract

Three Japanese adolescents with chronic hepatitis C were treated by direct-acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.

Keywords: Japanese; adolescents; chronic hepatitis C; direct‐acting antivirals; special population.

Publication types

Case Reports